Details about the neuroanatomical projections from CA1 to EPv
To view more data and metadata associated with each report, click on its ID.
Report ID | Sending structure |
Receiving structure | Projection strength | Technique | General description projection | Collator | Associated reference |
88644 |
Field CA1 | Endopiriform nucleus ventral part |
light | biotinylated dextran amine (BDA) | Collator note: labeling of the EPv, mainly dorsally. See Fig. 4B-D, Swanson Atlas Levels 26-32 | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
88703 |
Field CA1 | Endopiriform nucleus ventral part |
light | biotinylated dextran amine (BDA) | Collator note: few fibers and terminals in the EPv (BLV of authors), rostrocaudally. See Fig. 7B-C, Swanson Atlas Levels 27-29. | Kishi T., Tsumori T., Yokota S. & Yasui Y.
, 2006 |
---|
General description technique/protocol: In case R53, BDA was injected into a temporal portion of field CA1 that abuts on the rostral Sv (Fig. 1A). Collator note: injection completely included in the CA1, rostro-ventral. The injection site is annotated here onto Swanson Atlas Level 37 (-5.3 mm f |
Further details associated to record number 88644:
Position of injection: rostro-ventral |
Topological position of injection: is contained |
Extension of injection outside: none |
The injection was performed in: left hemisphere |
| Position of terminal field: everywhere |
Topological position of terminal field: is contained |
Extension of terminal field outside: none |
The terminal field was found: ipsilateral |
| |